Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 2.   Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum
  2. Shmueli, A.; Tsai, Y. C.; Yang, M.; Braun, M. A.; Weissman, A. M.
  3. Biochemical and Biophysical Research Communications. 2009 390(3): 758-762.
  1. 3.   Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome
  2. Tandle, A. T.; Calvani, M.; Uranchimeg, B.; Zahavi, D.; Melillo, G.; Libutti, S. K.
  3. Experimental Cell Research. 2009 315(11): 1850-1859.
  1. 4.   The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain,, RING finger, and an E2-binding site
  2. Chen, B.; Mariano, J.; Tsai, Y. C.; Chan, A. H.; Cohen, M.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 10; 103(2): 341-346.
  1. 5.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 6.   The role of IL-6 and STAT3 in inflammation and cancer
  2. Hodge, D. R.; Hurt, E. M.; Farrar, W. L.
  3. European Journal of Cancer. 2005, NOV; 41(16): 2502-2512.
  1. 7.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
  1. 8.   Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation
  2. Hodge, D. R.; Peng, B.; Cherry, J. C.; Hurt, E. M.; Fox, S. D.; Kelley, J. A.; Munroe, D. J.; Farrar, W. L.
  3. Cancer Research. 2005, JUN 1; 65(11): 4673-4682.
  1. 9.   Co-operative functions between nuclear factors NF kappa B and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Prostate. 2004, DEC 1; 61(4): 354-370.
  1. 10.   Induction of stem cell factor/c-Kit/Slug signal transduction in multidrug-resistant malignant mesothelioma cells
  2. Catalano, A.; Rodilossi, S.; Rippo, M. R.; Caprari, P.; Procopio, A.
  3. Journal of Biological Chemistry. 2004, NOV 5; 279(45): 46706-46714.
  1. 11.   NF-kappa B activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NF kappa B regulatory site in autocrine human multiple myeloma cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004, OCT; 3(10): 1007-1017.
  1. 12.   Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells
  2. Hodge, D. R.; Xiao, W. H.; Wang, L. H.; Li, D. P.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004 3(2): 188-194.
  1. 13.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 14.   Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFN gamma: an approach for gene therapy
  2. Pastorino, S.; Carta, L.; Puppo, M.; Melillo, G.; Bosco, M. C.; Varesio, L.
  3. Gene Therapy. 2004 11(6): 560-568.
  1. 15.   Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells
  2. Wessells, J.; Yakar, S.; Johnson, P. F.
  3. Molecular and Cellular Biology. 2004 24(8): 3238-3250.
  1. 16.   Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell- factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation
  2. Akel, S.; Petrow-Sadowski, C.; Laughlin, M. J.; Ruscetti, F. W.
  3. Stem Cells. 2003 21(5): 557-567.
  1. 17.   RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer
  2. Fang, S.; Lorick, K. L.; Jensen, J. P.; Weissman, A. M.
  3. Seminars in Cancer Biology. 2003 13(1): 5-14.
  1. 18.   Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: Potential physiological and clinical relevance
  2. Ruscetti, F. W.; Bartelmez, S. H.
  3. International Journal of Hematology. 2001 74(1): 18-25.
  1. 19.   Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells
  2. Ronen, D.; Altstock, R. T.; Firon, M.; Mittelman, L.; Sobe, T.; Resau, J. H.; Woude, G. F. V.; Tsarfaty, I.
  3. Cell Growth and Differentiation. 1999 10(2): 131-140.
  1. 20.   Diverse Tumorigenesis Associated With Aberrant Development in Mice Overexpressing Hepatocyte Growth Factor Scatter Factor
  2. Takayama, H.; Larochelle, W. J.; Sharp, R.; Otsuka, T.; Kriebel, P.; Anver, M.; Aaronson, S. A.; Merlino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(2): 701-706.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel